Products List
LIAISON Anti-HBe
LIAISON Anti-HBeThe LIAISON Anti-HBe assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of total antibodies to hepatitis B a antigen (anti-Bbe) in human serum or plasma samples. The test had to be perfom..
LIAISON Anti-Tg
LIAISON Anti-TgIn vitro assay for the quantitative determination of autoantibodies against thyroglobulin (Tg) in human serum as well as in EDTA and heparinised human plasma. The test has to be performed on the LIAISON Analyzer...
LIAISON Anti-TPO
LIAISON Anti-TPOIn vitro assay for the quantitative determination of autoantibodies against thyroid peroxidase (TPO) in human serum as well as in EDTA, citrated and heparinised human plasma. The test has to be performed on the LIAISON Analyzer...
LIAISON Biotrin Parvovirus B19 IgM
LIAISON Biotrin Parvovirus B19 IgMThe LIAISON Biotrin Parvovirus B19 IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to parvovirus B19 in human serum or plasma samples. ..
LIAISON Bordetella Pertussis Toxin
LIAISON Bordetella Pertussis ToxinPlease click below for more informationLIAISON Bordetella Pertussis Toxin IgG and IgA..
LIAISON Bordetella Pertussis Toxin IgA
LIAISON Bordetella Pertussis Toxin IgAThe LIAISON Bordetella pertussis Toxin IgG kit uses chemiluminescent immunoassay (CLIA) technology for the quantitative determination of IgA antibodies to Bordetella pertussis Toxin in human serum and plasma..
LIAISON Bordetella Pertussis Toxin IgG
LIAISON Bordetella Pertussis Toxin IgGThe LIAISON Bordetella pertussis Toxin IgG kit uses chemiluminescent immunoassay (CLIA) technology for the quantitative determination of IgA antibodies to Bordetella pertussis Toxin in human serum and plasma..
LIAISON Borrelia IgM II
LIAISON Borrelia IgM IIThe LIAISON Borrelia IgM II assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to Borrelia burgdorferi sensu lato in human serum or plasma samples. The t..
LIAISON Borrelia IgM Quant
LIAISON Borrelia IgM QuantThe LIAISON Borrelia IgM II assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgM antibodies to Borrelia burgdorferi sensu lato in human serum, plasma or cerebrosp..
LIAISON BRAHMS PCT II GEN
LIAISON BRAHMS PCT II GENLIAISON BRAHMS PCT II GEN assay uses chemiluminescence immunoassay (CLIA) technology for the in vitro quantitative determination of Procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunct..
LIAISON C-Peptid
LIAISON C-PeptidIn vitro assay for the quantitative determination of C-peptide in human serum, heparinised or citrated plasma, and urine. The test has to be performed on the LIAISON Analyzer family...
LIAISON C. difficile GDH
LIAISON C. difficile GDHThe DiaSorin LIAISON C. difficile GDH Assay is a chemiluminescent immunoassay (CLIA) intended for use as a screening assay to detect Clostridium difficile antigen, glutamate dehydrogenase, in human feces from persons susp..
LIAISON C. difficile Toxins A and B
LIAISON C. difficile Toxins A and BThe DiaSorin LIAISON C. difficile Toxins A&B Assay is a chemiluminescent immunoassay (CLIA) intended for the qualitative determination of Clostridium difficile toxins A and B in human feces on the LIAI..
LIAISON CA 125 II
LIAISON CA 125 IIIn vitro assay for the quantitative determination of CA 125 antigen in human serum as well as in EDTA or heparinised human plasma during the follow-up of patients with primary invasive ovarian carcinoma. The test has to be performed ..
LIAISON CA 15-3
LIAISON CA 15-3In vitro assay for the quantitative determination of the CA 15-3 antigen in human serum as well as EDTA and heparinised plasma during the follow-up of patients with breast carcinoma. The test has to be performed on the LIAISON&nbs..
LIAISON CA 19-9
LIAISON CA 19-9In vitro assay for the quantitative determination of the CA 19-9 antigen in human serum as well as EDTA or citrated human plasma during the follow-up of patients with gastrointestinal tumours. The test has to be performed on the LIAISO..
LIAISON Calcitonin II-Gen
LIAISON Calcitonin II-GenThe DiaSorin LIAISON Calcitonin II-Gen Assay is a one-step sandwich chemiluminescence immunoassay (CLIA) intended for the quantitative determination of calcitonin in human serum. Assay results should be used in conjuncti..
LIAISON Calprotectin
LIAISON CalprotectinThe DiaSorin LIAISON Calprotectin Assay is an in vitro diagnostic chemiluminescent immunoassay (CLIA) intended for the quantitative measurement, in human stool, of fecal calprotectin, a neutrophilic prot..
LIAISON Campylobacter
LIAISON CampylobacterThe LIAISON Campylobacter assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of Campylobacter antigens in human stool specimens. The test may be used as an aid in the diagnosis o..
LIAISON Cardiolipin IgG
LIAISON Cardiolipin IgGThe LIAISON Cardiolipin IgG assay uses chemiluminescent immunoassay (CLIA) technology for the in vitro semi-quantitative determination of autoantibodies of IgG class directed against cardiolipin in human serum or plasma sa..
LIAISON Cardiolipin IgM
LIAISON Cardiolipin IgMThe LIAISON Cardiolipin IgM assay uses chemiluminescent immunoassay (CLIA) technology for the in vitro semiquantitative determination of autoantibodies of IgM class directed against cardiolipin in human serum or plasma sam..
LIAISON CEA
LIAISON CEAIn vitro assay for the quantitative determination of carcinoembryonic antigen (CEA) in human serum as well as in EDTA or heparinised human plasma during the follow-up of cancer patients. The test has to be performed on the LIAISON Ana..
LIAISON Chalmydia Trachomatis IgA
LIAISON Chalmydia Trachomatis IgAThe LIAISON Chalmydia trachomatis IgA assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgG antibodies to Chlamydia trachomatis in human serum or plasma samp..
LIAISON CMV IgG Avidity II
LIAISON CMV IgG Avidity IIThe LIAISON CMV IgG Avidity II assay uses chemiluminescence immunoassay (CLIA) technology for the determination of antigen-binding avidity of IgG antibodies to hCMV in human serum or plasma samples. The test has to be p..